Multi-Year Supply Agreement Signed with Top-5 European Pharma

keruihk has entered a multi-year exclusive supply agreement for three oncology peptide APIs with a leading European pharmaceutical company, valued at over $45M. The agreement covers GMP-grade supply of three proprietary peptide APIs for Phase III clinical trials and commercial launch.

← Back to News
Newsletter

Stay Ahead in
Peptide Science

Join 5,000+ pharmaceutical and biotech professionals who receive our monthly newsletter — covering product launches, regulatory updates, and industry insights.

  • New product launches & catalog updates
  • Regulatory news & compliance updates
  • Industry trends & market insights
  • Company milestones & partnerships

Subscribe to Our Newsletter

Monthly digest, no spam. Unsubscribe anytime.

By subscribing, you agree to our Privacy Policy. No spam, ever.